BeStock  
Stocks › Biotechnology › ADMA

ADMA Biologics ADMA

US equityMarket cap rank #2453Biotechnology
$13.17 −$0.17 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.30 +0.99%
Open$13.26
Prev close$13.34
Day range$13.10 – $13.47
Volume2.45M
Market cap$2.92B
P/E (TTM)17.1
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership89.9%-1.35 pts vs. prior quarter
Institutions holding389+13 vs. prior quarter
Insider trades (recent)23 buys / 25 sellsNet selling
Short interest8.05% of floatDays to cover 7.1 · as of 30 Oct 2026
Short-sale volume share18.9%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%24%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$15.83M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$12.6MSuper−$3.2MBig+$4.0MMid+$4.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.6% of shares outstanding.

Largest holders

  • BlackRock16.82%
  • State Street Global Advisors6.16%
  • Vanguard Capital Management, LLC4.27%
  • Rubric Capital Management LP4.21%
  • Vanguard Portfolio Management, LLC4.15%
  • Capital Research3.94%
  • First Trust Advisors L.P.3.52%
  • Geode Capital Management, LLC2.67%

By investor type

  • Mutual Fund62.35%
  • Hedge Fund17.92%
  • Public Company3.96%
  • Individual/Insider1.89%
  • Government Pension Fund1.46%
  • Family Office/Trust1.46%
  • Private Company1.38%
  • VC/PE Fund1.12%

Reported short interest has fallen from 10.13% to 8.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
First Trust Advisors L.P. Mutual Fund 2026/Q3 +2,242,671 4.5%
JPMorgan Chase & Co. Public Company 2026/Q3 +561,050 0.3%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +514,606 0.2%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +497,985 0.8%
Clark Estates Inc. Family Office/Trust 2026/Q3 +278,000 0.1%
Bridge City Capital, LLC Mutual Fund 2026/Q3 +265,689 0.1%
Frontier Capital Management Mutual Fund 2026/Q3 +785,781 0.4%
Rubric Capital Management LP Hedge Fund 2026/Q3 +7,530,006 4.2%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +7,438,134 3.5%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +4,713,770 2.4%
State Street Global Advisors Mutual Fund 2026/Q3 +3,031,817 7.6%
Nantahala Capital Management, LLC Hedge Fund 2026/Q3 +2,359,993 1.1%
BlackRock Mutual Fund 2026/Q3 +1,524,910 17.1%
Life Cycle Investment Partners Limited Mutual Fund 2026/Q3 +1,522,981 0.7%
Kennedy Capital Management LLC Mutual Fund 2026/Q3 +1,343,805 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
4 Nov 2026 Adam Grossman Chief Executive Officer Open Market Disposition -42,000 $12.00 2,901,326
4 Nov 2026 Adam Grossman Chief Executive Officer Derivative Exercise and Sale -105,000 $12.00 2,901,326
23 Jul 2026 Kaitlin Kestenberg COO & Senior VP of Compliance Sale to Issuer -3,177 $8.37 165,682
15 Jul 2026 P. Terence Kohler Chief Financial Officer Other Acquisition +85,130 – 143,149
15 Jul 2026 P. Terence Kohler Chief Financial Officer Other Derivative Acquisition +136,363 $8.81 136,363
26 May 2026 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +6,400 $7.91 564,007
11 May 2026 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +12,500 $8.01 557,607
10 May 2026 Jerrold Grossman Co-Founder & Vice Chairman of the Board Open Market Acquisition +12,500 $8.01 545,107
31 Mar 2026 Kaitlin Kestenberg COO & Senior VP of Compliance Sale to Issuer -20,362 $9.11 161,359
16 Mar 2026 Lawrence Guiheen Independent Director Other Acquisition +30,000 – 175,820
16 Mar 2026 Lawrence Guiheen Independent Director Derivative Exercise and Sale -30,000 – 175,820
15 Mar 2026 Adam Grossman Chief Executive Officer Automatic Disposition -6,000 $15.16 2,943,326
15 Mar 2026 Adam Grossman Chief Executive Officer Derivative Exercise and Sale -15,000 $15.16 2,943,326
9 Mar 2026 Brad Tade Former Consultant Intent to Sell (Form 144) -50,026 $15.81 –
8 Mar 2026 Kaitlin Kestenberg COO & Senior VP of Compliance Other Disposition -91,266 – 133,641
8 Mar 2026 Kaitlin Kestenberg COO & Senior VP of Compliance Derivative Exercise and Sale -10,096 $15.63 133,641
6 Mar 2026 Adam Grossman Chief Executive Officer Sale to Issuer -85,951 $15.39 2,949,326
6 Mar 2026 Kaitlin Kestenberg COO & Senior VP of Compliance Sale to Issuer -14,294 $15.39 133,641
5 Mar 2026 Aisling Capital Management LP Open Market Acquisition +14,000 $15.67 –
25 Feb 2026 P. Terence Kohler Chief Financial Officer Initial Statement of Beneficial +0 – 58,019

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 18,035,119 8.1% 7.1
15 Oct 2026 19,528,063 8.7% 6.6
30 Sep 2026 20,597,867 9.2% 5.7
15 Sep 2026 24,206,749 10.8% 10.8
31 Aug 2026 23,870,475 10.7% 13.9
14 Aug 2026 22,683,647 10.1% 8.0

Discussion

No comments yet — be the first to weigh in on ADMA.

Sign in to join the discussion.

Scroll to Top